Manila, Philippines—GetMEDS Philippines, Inc., an emerging online pharmacy, expands its product portfolio with the inclusion of Fingolimod, a medicine intended for patients with multiple sclerosis.
Fingolimod is prescribed to treat relapsing-remitting forms of multiple sclerosis (MS) for both adults and children 10 years of age and older. By reducing an overactive immmune system, the medicine prevents or delays progressive deterioration. It comes in 500 microgram capsules and is a member of the drug class known as Disease-Modifying Medications.
This action seeks to reinforce GetMEDS’ pharmaceutical offerings with treatments targeting rare diseases and to strengthen its unceasing commitment to making healthcare accessible to all.
“With a focus on accessibility, we aim to make this innovative product readily available to improve the quality of life for individuals facing specific health challenges.” said Naresh Bishnoi, the Director of GetMEDS.
The company also emphasized its gratitude to be one of the few companies to provide Fingolimod and to offer the best price in the Philippine market.
GetMEDS, established in 2022, has a various portfolio that spans multiple therapeutic areas—Oncology, Hematology, and other uncommon conditions.
Fingolimod is available for purchase on GetMEDS’ website and is ready to deliver nationwide. To learn more about the product, just visit www.getmeds.ph
For more information, contact:
Phone: +639190769105 Email: email@example.com Website: www.getmeds.ph